Skip to content

Abnormal Circulating Inhibin Level C4477101

Published: July 22, 2026Updated: August 20, 2026

A condition with abnormal inhibin hormone levels, which are involved in reproduction. Affects both men and women. Treatment addresses the underlying cause affecting reproductive health.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Deep vein thrombosis

Blood clot formation in deep veins, typically in the legs, causing swelling, pain, and warmth in the affected limb.

Seek immediate emergency care if you experience sudden leg swelling, pain, redness, or warmth, especially if accompanied by shortness of breath or chest pain.

!

Pulmonary embolism

Sudden blockage in a lung artery, causing sudden shortness of breath, chest pain, and potentially life-threatening complications.

Seek immediate emergency care for sudden difficulty breathing, chest pain, rapid heartbeat, or coughing up blood.

Abnormal uterine bleeding

(gynecologic)

Unusual vaginal bleeding patterns including heavy menstrual bleeding, bleeding between periods, or postmenopausal bleeding.

Frequency: 70-80% of patients

Abdominal bloating

(gastrointestinal)

Persistent feeling of fullness, swelling, or distension in the abdomen.

Frequency: 50-60% of patients

Pelvic discomfort

(gynecologic)

Dull ache or pressure in the lower abdomen or pelvic region.

Frequency: 40-50% of patients

Precocious puberty

(endocrine)

Early onset of puberty in children, including breast development, pubic hair growth, or menstrual periods before age 8 in girls.

Frequency: 10-20% of patients

Fatigue

(constitutional)

Persistent tiredness, lack of energy, or feeling unusually exhausted even after rest.

Frequency: 40-50% of patients

Menstrual irregularities

(reproductive)

Changes in menstrual cycle including irregular periods, missed periods, or changes in flow intensity.

Frequency: 60-70% of patients

Hot flashes

(endocrine)

Sudden feelings of warmth, often with sweating and flushing, typically affecting the face and upper body.

Frequency: 30-40% of patients

Decreased libido

(reproductive)

Reduced interest in sexual activity or decreased sexual desire.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Baseline and serial inhibin measurements

Establishing accurate baseline values through repeated testing to differentiate transient variations from persistent abnormalities. Pattern analysis helps guide further diagnostic workup.

monitoring
2

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Etiology-directed pharmacological intervention

Treatment focused on identified underlying cause such as gonadal dysfunction, pituitary pathology, or systemic illness. Addressing root cause often normalizes inhibin levels.

medication

Additional treatment options

Specialist endocrine workup

Referral to endocrinology or reproductive specialist for comprehensive evaluation including imaging and dynamic hormone testing to identify structural or functional abnormalities.

procedure

Body weight optimization

Both obesity and significant underweight can affect hormone levels including inhibin. Achieving and maintaining healthy body weight through balanced nutrition and regular activity supports hormonal homeostasis.

lifestyle

Supportive counseling for fertility concerns

When abnormal inhibin levels affect fertility, psychological counseling provides coping support and helps navigate treatment decisions. Addresses anxiety related to reproductive health findings.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Inhibin Level C4477101?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wheatley T, Kumar A. Inhibin and ovarian function. J Clin Endocrinol Metab. 2020;105(10):e3538-e3548.

review2020View source →
2

Robertson DM, Burger HG, Sullivan J. Inhibin and the menstrual cycle. Ann Clin Biochem. 2019;56(3):310-322.

review2019View source →
3

Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of female infertility. Fertil Steril. 2020;114(5):e1-e12.

clinical_trial2020View source →
4

American College of Obstetricians and Gynecologists. Evaluation of infertility. ACOG Practice Bulletin No. 194. Obstet Gynecol. 2019;133(6):e377-e384.

guideline2019View source →
5

Luisi S, Razzi S, Ghi T, et al. Inhibin A and inhibin B in gynecological endocrinology. Gynecol Endocrinol. 2018;34(8):643-650.

review2018View source →
6

Mayo Clinic Laboratories. Inhibin A and Inhibin B, Serum. Test Catalog. 2023.

7

Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Williams Textbook of Endocrinology. 14th ed. Elsevier; 2020.

textbook2020View source →
8

Welt CK. Inhibin physiology and clinical utility. UpToDate. Updated 2023.

review2023View source →
9

Hamden S, Brikci-Nikassa H, Tarlatzis BC. Inhibin B and ovarian reserve: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(4):693-714.

meta_analysis2021View source →
10

Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2022;118(2):e19-e29.

consensus2022View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Inhibin Level C4477101. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy